Get started
Author

Costanza Galli

Hypersensitivity reactions related to oxaliplatin (OHP)
2003 · G Brandi, M A Pantaleo, et al. · British Journal of Cancer · 138
PDF
Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refractory Prostate Cancer
2009 · Andrea Fontana, Luca Galli, et al. · Clinical Cancer Research · 88
Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study.
2013 · Fable Zustovich, Lorenza Landi, et al. · PubMed · 68
Temozolomide as First-Line Agent in Treating High-Grade Gliomas: Phase II Study
2004 · S. Chibbaro, L. Benvenuti, et al. · Journal of Neuro-Oncology · 41
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)
2003 · F. Di Costanzo, A. Sobrero, et al. · Annals of Oncology · 28
Sorafenib plus daily low dose temozolomide for relapsed glioblastoma: A phase II study.
2011 · F. Zustovich, L. Landi, et al. · Journal of Clinical Oncology · 27
Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study
1999 · Alfredo Falcone, Giacomo Allegrini, et al. · Cancer Chemotherapy and Pharmacology · 16
Suramin in Combination with 5-Fluorouracil (5-FU) and Leucovorin (LV) in Metastatic Colorectal Cancer Patients Resistant to 5-FU+LV-Based Chemotherapy
1998 · Alfredo Falcone, Elisabetta Pfanner, et al. · Tumori Journal · 14
Phase II study of sequential chemotherapy with docetaxel–estramustine followed by mitoxantrone–prednisone in patients with advanced hormone-refractory prostate cancer
2007 · L Galli, A Fontana, et al. · British Journal of Cancer · 6
PDF
5-Fluorouracil Administered as a 48-Hour Semiintermittent Infusion in Combination With Leucovorin, Cisplatin and Epirubicin
2004 · Giacomo Allegrini, Alfredo Falcone, et al. · American Journal of Clinical Oncology · 2
Low-dose metronomic cyclophosphamide plus celecoxib and dexamethasone in advanced hormone refractory prostate cancer (HRPC): a phase II clinical trial with evaluation of clinical, biologic and pharmacodynamic effects of the combination
2006 · Antonella Fontana, Guido Bocci, et al. · CINECA IRIS Institutial research information system (University of Pisa) · 1
A phase I and pharmacokinetic study of irinotecan given as a 7 days continuous infusion in metastatic colorectal cancer patients pretreated with 5-FU or raltitrexed
2001 · G. Masi, A. Di Paolo, et al. · European Journal of Cancer · 1
Metronomic oral vinorelbine (V) and dexamethasone (D) in patients with advanced castration resistant prostate cancer (CRPC): a phase II clinical study with pharmacokinetic (PK) and pharmacodynamic (PD) evaluations
2009 · Laura Galli, Antonella Fontana, et al. · CINECA IRIS Institutial research information system (University of Pisa)
Docetaxel-prednisone (DP) plus metronomic cyclophosphamide (CTX) and celecoxib (C) as first line treatment in castration resistant prostate cancer (CRPC): phase II trial with pharmacodynamic evaluation
2009 · Antonella Fontana, Laura Galli, et al. · CINECA IRIS Institutial research information system (University of Pisa)
Docetaxel (D) plus prednisone (P) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) as first line chemotherapy in metastatic hormone refractory prostate cancer (HRPC): Phase II clinical trial with pharmacodynamic evaluation
2008 · A. Fontana, G. Bocci, et al. · Journal of Clinical Oncology
Retrospective analysis of concomitant treatment with 3-dimensional conformal radiotherapy and temozolomide in high-grade glioma patients
2008 · Lorenza Landi, Andrea Fontana, et al. · CINECA IRIS Institutial research information system (University of Pisa)
Phase II clinical trial with pharmacodynamic evaluation of docetaxel/prednisone plus metronomic cyclophosphamide and celecoxib as first line treatment in metastatic hormone refractory prostate cancer (MHRPC)
2008 · Antonella Fontana, Guido Bocci, et al. · CINECA IRIS Institutial research information system (University of Pisa)
4029 POSTER Phase II clinical trial of metronomic cyclophosphamide (CTX) plus celecoxib (C) and dexamethasone (DEX) in advanced hormone refractory prostate cancer (HRPC): preliminary clinical and pharmacodynamic results
2007 · A. Fontana, G. Bocci, et al. · European Journal of Cancer Supplements
Phase II clinical trial of metronomic cyclophosphamide (CTX) plus celecoxib ( C ) and dexamethasone (DEX) in advanced hormone refractory prostate cancer (HRPC): preliminary clinical and pharmacodynamic results
2007 · Antonella Fontana, Guido Bocci, et al. · CINECA IRIS Institutial research information system (University of Pisa)
582 A phase I study of day 1 and 8 every three weeks docetaxel infusion
2003 · P.G. Giannessi, R. Di Marsico, et al. · European Journal of Cancer Supplements
[High-dose nitrosourea in a case of non-Hodgkin's lymphoma].
1984 · G Segalini, R De Maria, et al. · PubMed
Works count: 21
Citation count: 430
H-index: 8
I10-index: 8
Year
Topic
Type